AGL 40.28 Increased By ▲ 0.07 (0.17%)
AIRLINK 127.65 Increased By ▲ 0.01 (0.01%)
BOP 6.70 Increased By ▲ 0.03 (0.45%)
CNERGY 4.49 Increased By ▲ 0.04 (0.9%)
DCL 8.75 Increased By ▲ 0.02 (0.23%)
DFML 41.10 Decreased By ▼ -0.06 (-0.15%)
DGKC 86.80 Increased By ▲ 0.69 (0.8%)
FCCL 33.10 Increased By ▲ 0.54 (1.66%)
FFBL 64.75 Increased By ▲ 0.37 (0.57%)
FFL 11.45 Decreased By ▼ -0.16 (-1.38%)
HUBC 112.10 Decreased By ▼ -0.36 (-0.32%)
HUMNL 14.95 Increased By ▲ 0.14 (0.95%)
KEL 5.17 Increased By ▲ 0.13 (2.58%)
KOSM 7.45 Increased By ▲ 0.09 (1.22%)
MLCF 40.45 Increased By ▲ 0.12 (0.3%)
NBP 61.30 Increased By ▲ 0.22 (0.36%)
OGDC 193.40 Decreased By ▼ -0.78 (-0.4%)
PAEL 27.02 Increased By ▲ 0.11 (0.41%)
PIBTL 7.36 Increased By ▲ 0.08 (1.1%)
PPL 154.00 Increased By ▲ 1.32 (0.86%)
PRL 26.47 Increased By ▲ 0.25 (0.95%)
PTC 16.45 Increased By ▲ 0.31 (1.92%)
SEARL 85.80 Increased By ▲ 0.10 (0.12%)
TELE 7.65 Decreased By ▼ -0.02 (-0.26%)
TOMCL 33.67 Decreased By ▼ -2.80 (-7.68%)
TPLP 8.75 Decreased By ▼ -0.04 (-0.46%)
TREET 16.70 Decreased By ▼ -0.14 (-0.83%)
TRG 63.02 Increased By ▲ 0.28 (0.45%)
UNITY 28.21 Increased By ▲ 0.01 (0.04%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
BR100 10,135 Increased By 49.4 (0.49%)
BR30 31,261 Increased By 90.6 (0.29%)
KSE100 95,220 Increased By 456.8 (0.48%)
KSE30 29,530 Increased By 119.5 (0.41%)
World

UK doesn't have vaccine surplus to share

  • "Our first priority is to protect the British public, and the vaccine rollout is continuing to that end," the spokesman told reporters. "We don't currently have a surplus of vaccines, but we will consider how they are best allocated as they become available."
Published March 29, 2021

LONDON: Britain does not currently have a surplus of COVID-19 vaccines to share with other countries, but will consider how to share any future surplus if there is one, Prime Minister Boris Johnson's spokesman said on Monday

"Our first priority is to protect the British public, and the vaccine rollout is continuing to that end," the spokesman told reporters. "We don't currently have a surplus of vaccines, but we will consider how they are best allocated as they become available."

Comments

Comments are closed.